NPORT-EX 2 NPORT_2775178861752505.htm iShares Evolved US Healthcare Staples ETF

Schedule of Investments (unaudited)

October 31, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
                                                     

Common Stocks

 

Biotechnology — 3.7%  

Amgen Inc.

     216     $ 46,859  

Bio-Rad Laboratories Inc., Class A(a)

    97       56,883  

Exact Sciences Corp.(a)

    748       92,625  

Guardant Health Inc.(a)

    244       26,025  

Illumina Inc.(a)

    910       266,357  

Livongo Health Inc.(a)(b)

    197       27,534  

Myriad Genetics Inc.(a)

    414       5,146  

NeoGenomics Inc.(a)

    540       21,184  

Veracyte Inc.(a)

    315       10,918  
   

 

 

  
      553,531  
Commercial Services — 0.5%  

Adtalem Global Education Inc.(a)

    179       4,196  

AMN Healthcare Services Inc.(a)

    297       19,388  

Bright Horizons Family Solutions Inc.(a)

    144       22,759  

Grand Canyon Education Inc.(a)

    137       10,736  

HMS Holdings Corp.(a)

    585       15,573  

Laureate Education Inc., Class A(a)

    306       3,978  

Strategic Education Inc.

     45       3,738  
   

 

 

  
      80,368  
Computers — 0.2%  

Leidos Holdings Inc.

     188       15,604  

MAXIMUS Inc.

     269       18,179  
   

 

 

  
      33,783  
Electrical Components & Equipment — 0.1%  

Novanta Inc.(a)

    161       17,504  
   

 

 

  
Electronics — 1.3%  

Agilent Technologies Inc.

     1,002       102,294  

OSI Systems Inc.(a)

    81       6,250  

PerkinElmer Inc.

     425       55,059  

Waters Corp.(a)

    163       36,320  
   

 

 

  
      199,923  
Environmental Control — 0.1%  

Stericycle Inc.(a)

    125       7,788  
   

 

 

  
Food Service — 0.0%  

Healthcare Services Group Inc.

     323       7,390  
   

 

 

  
Health Care - Products — 49.5%  

10X Genomics Inc., Class A(a)

    118       16,154  

Abbott Laboratories

     12,649       1,329,536  

ABIOMED Inc.(a)

    279       70,275  

Adaptive Biotechnologies Corp.(a)

    152       7,004  

Align Technology Inc.(a)

    206       87,772  

AngioDynamics Inc.(a)

    216       2,233  

AtriCure Inc.(a)

    216       7,465  

Atrion Corp.

     9       5,410  

Avanos Medical Inc.(a)

    180       6,363  

Avantor Inc.(a)

    674       15,684  

Axogen Inc.(a)

    99       1,248  

Baxter International Inc.

     1,692       131,248  

Bio-Techne Corp.

     126       31,804  

BioTelemetry Inc.(a)

    207       8,814  

Boston Scientific Corp.(a)

    9,944       340,781  

Bruker Corp.

     342       14,549  

Cardiovascular Systems Inc.(a)

    189       6,738  

CareDx Inc.(a)

    245       12,017  

Cooper Companies Inc. (The)

     297       94,758  
Security   Shares     Value  
                                                     
Health Care - Products (continued)  

CryoLife Inc.(a)

    216     $ 3,620  

Cutera Inc.(a)

    63       1,193  

Danaher Corp.

     2,847       653,500  

DENTSPLY SIRONA Inc.

     755       35,628  

Edwards Lifesciences Corp.(a)

    4,347       311,636  

GenMark Diagnostics Inc.(a)(c)

    414       5,059  

Glaukos Corp.(a)

    126       7,046  

Globus Medical Inc., Class A(a)

    531       27,676  

Haemonetics Corp.(a)

    216       21,835  

Henry Schein Inc.(a)(c)

    713       45,333  

Hill-Rom Holdings Inc.

     326       29,689  

Hologic Inc.(a)

    1,396       96,073  

ICU Medical Inc.(a)

    90       16,001  

IDEXX Laboratories Inc.(a)

    357       151,661  

Inogen Inc.(a)

    117       3,418  

Inspire Medical Systems Inc.(a)

    110       13,137  

Insulet Corp.(a)

    404       89,789  

Integer Holdings Corp.(a)

    135       7,891  

Integra LifeSciences Holdings Corp.(a)

    378       16,670  

Intersect ENT Inc.(a)

    99       1,534  

Intuitive Surgical Inc.(a)

    788       525,659  

iRhythm Technologies Inc.(a)

    168       35,524  

LeMaitre Vascular Inc.

     99       3,216  

LivaNova PLC(a)

    325       16,360  

Luminex Corp.

     207       4,562  

Masimo Corp.(a)

    333       74,532  

Medtronic PLC

     9,253       930,574  

Merit Medical Systems Inc.(a)

    306       15,315  

Natera Inc.(a)

    388       26,097  

Natus Medical Inc.(a)

    189       3,442  

Nevro Corp.(a)

    144       21,486  

Novocure Ltd.(a)

    225       27,472  

NuVasive Inc.(a)

    324       14,395  

OraSure Technologies Inc.(a)

    351       5,244  

Orthofix Medical Inc.(a)

    107       3,345  

Patterson Companies Inc.

     362       9,005  

Penumbra Inc.(a)

    189       49,335  

Quidel Corp.(a)

    180       48,292  

ResMed Inc.

     890       170,827  

Shockwave Medical Inc.(a)

    136       9,292  

Silk Road Medical Inc.(a)

    161       9,757  

STAAR Surgical Co.(a)

    242       17,545  

STERIS PLC

     224       39,691  

Stryker Corp.

     2,279       460,381  

Tactile Systems Technology Inc.(a)

    119       4,353  

Tandem Diabetes Care Inc.(a)

    308       33,572  

Teleflex Inc.

     295       93,878  

Thermo Fisher Scientific Inc.

     1,575       745,164  

Varex Imaging Corp.(a)

    153       2,050  

Varian Medical Systems Inc.(a)

    414       71,539  

Wright Medical Group NV(a)(c)

    522       15,968  

Zimmer Biomet Holdings Inc.

     1,149       151,783  
   

 

 

  
      7,367,897  
Health Care - Services — 24.0%  

Acadia Healthcare Co. Inc.(a)

    576       20,534  

Addus HomeCare Corp.(a)

    74       7,220  

Amedisys Inc.(a)

    244       63,196  

Anthem Inc.

     1,304       355,731  

Centene Corp.(a)

    3,247       191,898  

Charles River Laboratories International
Inc.(a)

    81       18,444  
 

 

 

    

   1

Schedule of Investments (unaudited) (continued)

October 31, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
                                                     
Health Care - Services (continued)  

Chemed Corp.

     64     $ 30,612  

DaVita Inc.(a)

    540       46,575  

Encompass Health Corp.

     735       45,063  

Ensign Group Inc. (The)

     230       13,533  

Envista Holdings Corp.(a)

    510       13,474  

HCA Healthcare Inc.

     1,821       225,695  

Humana Inc.

     808       322,618  

Invitae Corp.(a)

    442       17,331  

IQVIA Holdings Inc.(a)

    595       91,624  

Laboratory Corp. of America Holdings(a)

    542       108,275  

LHC Group Inc.(a)

    190       41,144  

Magellan Health Inc.(a)

    108       7,805  

MEDNAX Inc.(a)

    605       7,714  

Medpace Holdings Inc.(a)

    65       7,211  

Molina Healthcare Inc.(a)

    140       26,106  

National HealthCare Corp.

     72       4,558  

Quest Diagnostics Inc.

     768       93,804  

Select Medical Holdings Corp.(a)

    792       16,616  

Syneos Health Inc.(a)

    108       5,733  

Teladoc Health Inc.(a)

    288       56,580  

Tenet Healthcare Corp.(a)

    657       16,123  

U.S. Physical Therapy Inc.

     108       8,568  

UnitedHealth Group Inc.

     5,396       1,646,535  

Universal Health Services Inc., Class B

     505       55,323  
   

 

 

  
      3,565,643  
Household Products & Wares — 0.3%  

Church & Dwight Co. Inc.

     511       45,167  
   

 

 

  
Pharmaceuticals — 17.0%  

AbbVie Inc.

     1,528       130,033  

AmerisourceBergen Corp.

     664       63,790  

Bausch Health Companies Inc.(a)(c)

    162       2,673  

Becton Dickinson and Co.

     1,737       401,473  

Cardinal Health Inc.

     1,500       68,685  

Cigna Corp.

     1,540       257,134  

CVS Health Corp.

     6,100       342,149  

DexCom Inc.(a)

    537       171,614  

Eli Lilly & Co.

     309       40,312  

Johnson & Johnson

     5,089       697,753  

McKesson Corp.

     704       103,833  

Neogen Corp.(a)

    81       5,649  

Perrigo Co. PLC

     132       5,791  

Pfizer Inc.

     5,287       187,583  

PRA Health Sciences Inc.(a)

    126       12,277  

Premier Inc., Class A

     423       13,845  

Zoetis Inc.

     154       24,417  
   

 

 

  
      2,529,011  
Real Estate Investment Trusts — 1.3%  

Healthpeak Properties Inc.

     1,016       27,402  
Security   Shares     Value  
                                                     
Real Estate Investment Trusts (continued)  

Medical Properties Trust Inc.

     2,079     $ 37,048  

National Health Investors Inc.

     180       10,089  

Omega Healthcare Investors Inc.

     466       13,425  

Physicians Realty Trust

     738       12,443  

Sabra Health Care REIT Inc.

     720       9,475  

Ventas Inc.

     862       34,023  

Welltower Inc.

     809       43,500  
   

 

 

  
      187,405  
Retail — 0.5%  

National Vision Holdings Inc.(a)

    172       6,937  

Walgreens Boots Alliance Inc.

     1,928       65,629  
   

 

 

  
      72,566  
Software — 1.0%  

Allscripts Healthcare Solutions Inc.(a)

    817       8,235  

Cerner Corp.

     1,459       102,261  

Change Healthcare Inc.(a)

    887       12,551  

Omnicell Inc.(a)

    179       15,493  

Tabula Rasa HealthCare Inc.(a)(c)

    90       3,109  
   

 

 

  
      141,649  
   

 

 

  

Total Common Stocks — 99.5%
(Cost: $12,677,732)

 

     14,809,625  
   

 

 

  

Short-Term Investments

 

Money Market Funds — 0.8%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.20%(d)(e)(f)

    54,774       54,812  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.04%(d)(e)

    66,000       66,000  
   

 

 

  
      120,812  
   

 

 

  

Total Short-Term Investments — 0.8%
(Cost: $120,779)

 

     120,812  
   

 

 

  

Total Investments in Securities — 100.3%
(Cost: $12,798,511)

 

     14,930,437  

Other Assets, Less Liabilities — (0.3)%

 

     (43,002 ) 
   

 

 

  

Net Assets — 100.0%

 

   $ 14,887,435  
   

 

 

  

 

(a) 

Non-income producing security.

(b) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(c) 

All or a portion of this security is on loan.

(d) 

Affiliate of the Fund.

(e) 

Annualized 7-day yield as of period-end.

(f) 

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

 

2  

    

Schedule of Investments (unaudited) (continued)

October 31, 2020

   

iShares® Evolved U.S. Healthcare Staples ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended October 31, 2020 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
07/31/20		      Purchases
at Cost		      Proceeds
from Sales		      Net Realized
Gain (Loss)		      Change in
Unrealized
Appreciation
(Depreciation)		      Value at
10/31/20		      Shares
Held at
10/31/20		      Income     

Capital

Gain
Distributions
from
Underlying
Funds

  

BlackRock Cash Funds: Institutional, SL Agency Shares

    $ 228,052      $ —      $ (173,194 )(a)     $ (72 )     $ 26      $ 54,812        54,774      $ 110 (b)     $ —  

BlackRock Cash Funds: Treasury,
SL Agency Shares

      66,000        —        0 (a)        —        —        66,000        66,000        19        —  
           

 

 

     

 

 

     

 

 

        

 

 

     

 

 

  
            $ (72 )     $ 26      $ 120,812         $ 129      $ —  
           

 

 

     

 

 

     

 

 

        

 

 

     

 

 

  

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to a recently published shareholder report. Shareholder reports are available on the Fund’s website at iShares.com and on the U.S. Securities and Exchange Commission website at sec.gov.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of October 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Investments

                  

Assets

                  

Common Stocks

    $ 14,782,091        $ —        $ 27,534        $ 14,809,625  

Money Market Funds

      120,812          —          —          120,812  
  

 

 

       

 

 

       

 

 

       

 

 

  
   $ 14,902,903        $             —        $     27,534        $ 14,930,437  
  

 

 

       

 

 

       

 

 

       

 

 

  

 

 

    

   3